Get ready for the 18th Bleeding and Thrombosing Diseases conference! This conference will provide reviews and updates about the laboratory and clinical aspects of bleeding and thrombosing disorders. It will take place Oct. 4–6, 2023, in Rochester, Minnesota.
Taking place on October 3–4, 2023, in Rochester, Minnesota, the Classical Hematology 2023 conference focuses on addressing the evaluation of frequently encountered blood count abnormalities. The conference will also provide the latest updates on the diagnosis and management of common and rare nonmalignant blood disorders.
Due to the Memorial Day holiday (recognized on Monday, May 29), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please plan ahead.
Visit Mayo Clinic Laboratories at booth #2047 to learn about our comprehensive therapeutics test offerings. Developed by board-certified experts in clinical chemistry, molecular, and toxicology testing, our testing is designed to detect and monitor therapeutic and illicit drugs across several relevant specimen types.
Join us for the APA Annual Meeting 2023, the premier event for psychiatrists and mental health professionals. This year's meeting will be held May 20–24 in San Francisco and will feature an exciting program of educational sessions, expert speakers, and networking opportunities.
In April 2023, Mayo Clinic Laboratories announced 10 new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
A medical mystery surrounding a clotting disease spurred a collaboration between Mayo Clinic and University of Michigan Health to develop a new test methodology and the discovery of a previously unknown blood clotting condition.
Top highlights include: US adult cigarette smoking rate hits new all-time low, ongoing search for long COVID treatment continues, and scientists try to understand the impact of social media on teens.
A specific type of fungal species, Candida auris, is raising concern in health care facilities around the world. First discovered in Japan in 2009, Candida auris is responsible for an increasing number of serious and often fatal fungal infections. Nancy Wengenack, Ph.D., director of the Mycology and Mycobacteriology Laboratories at Mayo Clinic Laboratories, explains why these infections are difficult to treat.
Thank you to all laboratory professionals for their efforts to provide critical answers for patients every day, and drive innovation in the field of medicine.
Top highlights include: Millions expected to lose dental care coverage, overdose deaths of elderly on the rise, and Minnesota Health Department urges caution for well owners as flood waters rise.
Matthew Binnicker, Ph.D., director of Mayo Clinic’s Clinical Virology Laboratory, provides insight on the newest COVID-19 subvariant – XBB.1.16, also known as “Arcturus.”
Matthew Binnicker, Ph.D., director of Mayo Clinic’s Clinical Virology Laboratory, provides an update on the ongoing global avian influenza outbreak and what’s being done to prepare for a potential human-to-human outbreak.